Regulatory PathRegulatory requirements compared

Active substances

Chlorphenamine + Paracetamol + Pseudoephedrine

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
ADOL ALLERGY SINUS 325MG-2MG-30MG CAPLET325,30,2 mg,mg,mgTablet · Oral use24 BlisterSAR 10.90NCE · OTCGulf Pharmaceutical Industries (Julphar)Valid
FEVADOL COLD & FLU TABLETS500,30,2 mg,mg,mgTablet · Oral use30 BlisterSAR 15.00Generic · OTCSPIMACO ADDWAEIHValid
FLUDREX SYRUP120,15,0.75 mg,mg,mgSyrup · Oral use1 BottleSAR 12.00Generic · OTCKUWAIT SAUDI PHARMACEUTICAL INDUSTRIESValid
FLUDREX SYRUP1440,180,9 mg,mg,mgSyrup · Oral use1 BottleSAR 2.90Generic · OTCKUWAIT SAUDI PHARMACEUTICAL INDUSTRIESValid
PANADOL COLD & FLU CAPLET500,30,2 mg,mg,mgTablet · Oral use24 BlisterSAR 12.30Generic · OTCHaleon Australia Pty LtdValid
EMIDOL COLD SYRUP24,3,0.4 mg,mg,mgSyrup · Oral use1 BottleSAR 4.00Generic · OTCGLOBAL PHARMAWithdrawn by MAH · Not Marketed
FLUDREX SINUS CAPLETS416.6 , 3 , 30 mgTablet · Oral use24 BlisterSAR 7.10Generic · OTCKUWAIT SAUDI PHARMACEUTICAL INDUSTRIESWithdrawn by MAH · Not Marketed

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
CHILDREN'S TYLENOL COLD020399821 MG / 5 ML; 15 MG / 5 ML; 160 MG / 5 MLSUSPENSION · ORALKENVUE CANADA INC.
EXTRA STRENGTH ALLERGY SINUS MEDICATION021595462 MG; 30 MG; 500 MGTABLET · ORALVITA HEALTH PRODUCTS INC
EXTRA STRENGTH SINUTAB SINUS & ALLERGY019869882 MG; 30 MG; 500 MGTABLET · ORALKENVUE CANADA INC.
EXTRA STRENGTH TYLENOL COLD & SINUS NIGHTTIME023480982 MG; 30 MG; 500 MGTABLET · ORALKENVUE CANADA INC.

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.